At close: December 13 at 4:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 2 | 2 |
| Avg. Estimate | -0.39 | 0 | -1.61 | -1.64 |
| Low Estimate | -0.39 | 0 | -1.68 | -1.79 |
| High Estimate | -0.39 | 0 | -1.53 | -1.49 |
| Year Ago EPS | -- | -- | -1.89 | -1.61 |
Revenue Estimate
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 3 | 3 |
| Avg. Estimate | -- | -- | 5M | 5M |
| Low Estimate | -- | -- | 5M | -- |
| High Estimate | -- | -- | 5M | 15M |
| Year Ago Sales | -- | -- | 7M | 5M |
| Sales Growth (year/est) | -- | -- | -28.57% | 0.00% |
Earnings History
| Currency in CHF | 9/30/2024 |
|---|---|
| EPS Est. | -0.54 |
| EPS Actual | -0.49 |
| Difference | 0.05 |
| Surprise % | 9.26% |
EPS Trend
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.39 | 0 | -1.61 | -1.64 |
| 7 Days Ago | -0.56 | 0 | -1.68 | -1.61 |
| 30 Days Ago | 0 | 0 | -1.68 | -1.61 |
| 60 Days Ago | 0 | 0 | -1.57 | -1.73 |
| 90 Days Ago | 0 | 0 | -1.57 | -1.73 |
EPS Revisions
| Currency in CHF | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MOLN | -- | -- | 15.08% | -2.18% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | JP Morgan: Neutral to Neutral | 12/5/2023 |
| Downgrade | SVB Leerink: Outperform to Market Perform | 8/29/2022 |
| Upgrade | Credit Suisse: Underperform to Neutral | 5/25/2022 |
| Maintains | SVB Leerink: Outperform | 4/27/2022 |
| Maintains | SVB Leerink: Outperform | 1/14/2022 |
| Maintains | SVB Leerink: Outperform | 8/27/2021 |
Related Tickers
BBIXF Bonus BioGroup Ltd.
0.0200
0.00%
3681.HK SinoMab BioScience Limited
1.050
-5.41%
6628.HK Transcenta Holding Limited
0.610
0.00%
1541.HK IMMUNEONCO-B
6.140
+1.99%
6978.HK Immunotech Biopharm Ltd
2.550
-7.27%
1167.HK JACOBIO-B
1.310
-5.07%
1521.HK FRONTAGE
1.560
+3.31%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
179.400
-4.37%
1530.HK 3SBIO
6.030
-1.95%
OTLC Oncotelic Therapeutics, Inc.
0.0300
+1.01%